|
1
|
Global Burden of Disease Cancer
Collaboration; Fitzmaurice C, Dicker D, Pain A, Hamavid H,
Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et
al: The Global Burden of Cancer 2013. JAMA Oncol. 1:505–527. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu N, Chen Z, Pang L, Ma Q and Chen G:
Prognostic significance of lymph node characteristics on survival
in esophageal squamous cell carcinomas. Wiener Klin Wochenschr.
125:26–33. 2013. View Article : Google Scholar
|
|
4
|
Miyasaka D, Okushiba S, Sasaki T, Ebihara
Y, Kawada M, Kawarada Y, Kitashiro S, Katoh H, Miyamoto M,
Shichinohe T and Hirano S: Clinical evaluation of the feasibility
of minimally invasive surgery in esophageal cancer. Asian J Endosc
Surg. 6:26–32. 2013. View Article : Google Scholar
|
|
5
|
Buderi SI, Shackcloth M and Page RD: Does
neoadjuvant chemoradiotherapy increase survival in patients with
resectable oesophageal cancer? Interact Cardiovasc Thorac Surg.
24:115–120. 2017. View Article : Google Scholar
|
|
6
|
Duan XF, Tang P and Yu ZT: Neoadjuvant
chemoradiotherapy for resectable esophageal cancer: An in-depth
study of randomized controlled trials and literature review. Cancer
Biol Med. 11:191–201. 2014.PubMed/NCBI
|
|
7
|
Hoffmann A, Natoli G and Ghosh G:
Transcriptional regulation via the NF-kappaB signaling module.
Oncogene. 25:6706–6716. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Milanovic M, Kracht M and Schmitz ML: The
cytokine-induced conformational switch of nuclear factor κB p65 is
mediated by p65 phosphorylation. Biochem J. 457:401–413. 2014.
View Article : Google Scholar
|
|
9
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar
|
|
10
|
Li B, Li YY, Tsao SW and Cheung AL:
Targeting NF-kappaB signaling pathway suppresses tumor growth,
angiogenesis, and metastasis of human esophageal cancer. Mol Cancer
Ther. 8:2635–2644. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim HJ, Hawke N and Baldwin AS: NF-kappaB
and IKK as therapeutic targets in cancer. Cell Death Differ.
13:738–747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramsbottom SA and Pownall ME: Regulation
of Hedgehog signalling inside and outside the cell. J Dev Biol.
4:232016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pak E and Segal RA: Hedgehog signal
transduction: Key players, oncogenic drivers, and cancer therapy.
Dev Cell. 38:333–344. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Agliano A, Calvo A and Box C: The
challenge of targeting cancer stem cells to halt metastasis. Semin
Cancer Biol. 44:25–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ruiz i Altaba A: Gli proteins encode
context-dependent positive and negative functions: Implications for
development and disease. Development. 126:3205–3216.
1999.PubMed/NCBI
|
|
16
|
Wei L and Xu Z: Cross-signaling among
phosphinositide-3 kinase, mitogen-activated protein kinase and
sonic hedgehog pathways exists in esophageal cancer. Int J Cancer.
129:275–284. 2011. View Article : Google Scholar
|
|
17
|
Min S, Xiaoyan X, Fanghui P, Yamei W,
Xiaoli Y and Feng W: The glioma-associated oncogene homolog 1
promotes epithelial-mesenchymal transition in human esophageal
squamous cell cancer by inhibiting E-cadherin via Snail. Cancer
Gene Therapy. 20:379–385. 2013. View Article : Google Scholar
|
|
18
|
Colavito SA, Zou MR, Yan Q, Nguyen DX and
Stern DF: Significance of glioma-associated oncogene homolog 1
(GLI1) expression in claudin-low breast cancer and crosstalk with
the nuclear factor kappa-light-chain-enhancer of activated B cells
(NFkappaB) pathway. Breast Cancer Res. 16:4442014. View Article : Google Scholar
|
|
19
|
Rice TW, Blackstone EH and Rusch VW: 7th
edition of the AJCC cancer staging manual: Esophagus and
esophagogastric junction. Ann Surg Oncol. 17:1721–1724. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
21
|
Mariette C, Piessen G and Triboulet JP:
Therapeutic strategies in oesophageal carcinoma: Role of surgery
and other modalities. Lancet Oncol. 8:545–553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mariette C, Dahan L, Mornex F, Maillard E,
Thomas PA, Meunier B, Boige V, Pezet D, Robb WB, Le Brun-Ly V, et
al: Surgery alone versus chemoradiotherapy followed by surgery for
stage I and II esophageal cancer: Final analysis of randomized
controlled phase III trial FFCD 9901. J Clin Oncol. 32:2416–2422.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
van Hagen P, Hulshof MC, van Lanschot JJ,
Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ,
Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, et al: Preoperative
chemoradiotherapy for esophageal or junctional cancer. N Engl J
Med. 366:2074–2084. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Koishi K, Yoshikawa R, Tsujimura T,
Hashimoto-Tamaoki T, Kojima S, Yanagi H, Yamamura T and Fujiwara Y:
Persistent CXCR4 expression after preoperative chemoradiotherapy
predicts early recurrence and poor prognosis in esophageal cancer.
World J Gastroenterol. 12:7585–7590. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoshikawa R, Fujiwara Y, Koishi K, Kojima
S, Matsumoto T, Yanagi H, Yamamura T, Hashimoto-Tamaoki T,
Nishigami T and Tsujimura T: Cyclooxygenase-2 expression after
preoperative chemoradiotherapy correlates with more frequent
esophageal cancer recurrence. World J Gastroenterol. 13:2283–2288.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van Olphen SH, Biermann K, Shapiro J,
Wijnhoven BP, Toxopeus EL, van der Gaast A, Stoop HA, van Lanschot
JJ, Spaander MC, Bruno MJ and Looijenga LH: P53 and SOX2 protein
expression predicts esophageal adenocarcinoma in response to
neoadjuvant chemoradiotherapy. Ann Surg. 265:347–355. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Leszczynska KB, Dobrynin G, Leslie RE,
Ient J, Boumelha AJ, Senra JM, Hawkins MA, Maughan T, Mukherjee S
and Hammond EM: Preclinical testing of an Atr inhibitor
demonstrates improved response to standard therapies for esophageal
cancer. Radiother Oncol. 121:232–238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li DJ, Shi M and Wang Z: RUNX3 reverses
cisplatin resistance in esophageal squamous cell carcinoma via
suppression of the protein kinase B pathway. Thorac Cancer.
7:570–580. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Izzo JG, Correa AM, Wu TT, Malhotra U,
Chao CK, Luthra R, Ensor J, Dekovich A, Liao Z, Hittelman WN, et
al: Pretherapy nuclear factor-kappaB status, chemoradiation
resistance, and metastatic progression in esophageal carcinoma. Mol
Cancer Ther. 5:2844–2850. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Izzo JG, Malhotra U, Wu TT, Ensor J,
Luthra R, Lee JH, Swisher SG, Liao Z, Chao KS, Hittelman WN, et al:
Association of activated transcription factor nuclear factor kappab
with chemoradiation resistance and poor outcome in esophageal
carcinoma. J Clin Oncol. 24:748–754. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yoshikawa R, Nakano Y, Tao L, Koishi K,
Matsumoto T, Sasako M, Tsujimura T, Hashimoto-Tamaoki T and
Fujiwara Y: Hedgehog signal activation in oesophageal cancer
patients undergoing neoadjuvant chemoradiotherapy. Br J Cancer.
98:1670–1674. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Agarwal NK, Kim CH, Kunkalla K, Konno H,
Tjendra Y, Kwon D, Blonska M, Kozloski GA, Moy VT, Verdun RE, et
al: Active IKKβ promotes the stability of GLI1 oncogene in diffuse
large B-cell lymphoma. Blood. 127:605–615. 2016. View Article : Google Scholar :
|
|
33
|
Nakashima H, Nakamura M, Yamaguchi H,
Yamanaka N, Akiyoshi T, Koga K, Yamaguchi K, Tsuneyoshi M, Tanaka M
and Katano M: Nuclear factor-kappaB contributes to hedgehog
signaling pathway activation through sonic hedgehog induction in
pancreatic cancer. Cancer Res. 66:7041–7049. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Benvenuto M, Fantini M, Masuelli L, De
Smaele E, Zazzeroni F, Tresoldi I, Calabrese G, Galvano F, Modesti
A and Bei R: Inhibition of ErbB receptors, Hedgehog and NF-kappaB
signaling by polyphenols in cancer. Front Biosci. 18:1290–1310.
2013. View Article : Google Scholar
|
|
35
|
Fitzgerald TL, Lertpiriyapong K, Cocco L,
Martelli AM, Libra M, Candido S, Montalto G, Cervello M, Steelman
L, Abrams SL and McCubrey JA: Roles of EGFR and KRAS and their
downstream signaling pathways in pancreatic cancer and pancreatic
cancer stem cells. Adv Biol Regul. 59:65–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li X, Chen F, Zhu Q, Ding B, Zhong Q,
Huang K, Jiang X, Wang Z, Yin C, Zhu Y, et al: Gli-1/PI3K/AKT/NF-kB
pathway mediates resistance to radiation and is a target for
reversion of responses in refractory acute myeloid leukemia cells.
Oncotarget. 7:33004–33015. 2016.PubMed/NCBI
|
